Wang, J.; Huang, Z.; Cao, Z.; Luo, Y.; Liu, Y.; Cao, H.; Tang, X.; Fang, G.
Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway. Int. J. Mol. Sci. 2024, 25, 11146.
https://doi.org/10.3390/ijms252011146
AMA Style
Wang J, Huang Z, Cao Z, Luo Y, Liu Y, Cao H, Tang X, Fang G.
Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway. International Journal of Molecular Sciences. 2024; 25(20):11146.
https://doi.org/10.3390/ijms252011146
Chicago/Turabian Style
Wang, Jing, Zheng Huang, Zhiyong Cao, Yehao Luo, Yueting Liu, Huilu Cao, Xiusong Tang, and Gang Fang.
2024. "Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway" International Journal of Molecular Sciences 25, no. 20: 11146.
https://doi.org/10.3390/ijms252011146
APA Style
Wang, J., Huang, Z., Cao, Z., Luo, Y., Liu, Y., Cao, H., Tang, X., & Fang, G.
(2024). Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway. International Journal of Molecular Sciences, 25(20), 11146.
https://doi.org/10.3390/ijms252011146
